LONDON, UK / ACCESSWIRE / March 28, 2023 / BioCorteX, a digital medicine company that employs the Carbon Mirror platform, a first-principle computer simulation to understand drug-bacteria interactions ...
LONDON, Oct. 9, 2024 /PRNewswire/ -- BioCorteX, a leading biotech innovator, today formally announced a breakthrough in the field of Antibody-Drug Conjugates (ADCs) for cancer treatment, achieved by ...
LONDON, November 24, 2025--(BUSINESS WIRE)--BioCorteX, the UK-based pioneering tech bio company, said Wednesday that it had entered into a strategic collaboration with Chinese biotech company CD ...
The company is developing precision medicine solutions using in silico simulation to solve the complex relationship bacteria, viruses and fungi play in health, disease and drug response Edward ...
formally announced a breakthrough in the field of Antibody-Drug Conjugates (ADCs) for cancer treatment, achieved by leveraging google Cloud technology. Through its advanced 'Unified Biology' approach, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results